Denali Capital Acquisition Corp Successfully Listed on Nasdaq Global Market (NASDAQ: DECAU)
Industry: Investment and Mergers & Acquisitions
Listing Date: 2022/4/7, NASDAQ
Funding Amount: 82.5 million USD
Partners: Tiger Brokers, EF Hutton
Yangkang Asset assisted Denali Capital Acquisition Corp. (NASDAQ: DECA) to successfully complete its listing on the Nasdaq Global Market in April 2022, raising over 82.5 million USD. Through over-allotment and private placements, the trust account resources were strengthened to provide robust capital support for the company’s search for acquisition targets. This funding round mainly focused on targets in technology, consumer services, or hospitality sectors, building an acquisition platform and implementing subsequent strategic acquisitions.
With this fundraising, Denali actively initiated acquisition negotiations and execution processes. In June 2025, the company extended the merger deadline with the target company Longevity Biomedical to July 11 and supplemented the trust account with an additional 874.78 USD to ensure the smooth progress of the transaction. Moving forward, the company will continue to seek quality targets for acquisitions according to its investment strategy, realizing effective integration of capital markets and industry value.